Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific announced today that its stockholders have approved a reverse stock split of the company's shares at a ratio of one for 50 to one for 60.

The ratio and timing of the split will be decided by the company's board of directors, Great Basin said. It added that the split would cure a previously announced authorized share failure, allowing Series C warrants to be exercisable for the next 25 trading days pursuant to the amended terms of the warrants disclosed earlier this week. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.